Related Experiment Video
Updated: May 17, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
1miRagen Therapeutics, 6200 Lookout Rd, Boulder, Colorado 80301, USA.
Abstract:
In recent years, prominent roles for microRNAs (miRNAs) have been uncovered in several cardiovascular disorders. The ability to therapeutically manipulate miRNA expression and function through systemic or local delivery of miRNA inhibitors, referred to as antimiRs, has triggered enthusiasm for miRNAs as novel therapeutic targets. Here, we focus on the pharmacokinetic and pharmacodynamic properties of current antimiR designs and their relevance to cardiovascular indications, and evaluate the opportunities and obstacles associated with this new therapeutic modality.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
MicroRNAs
MicroRNAs
MicroRNAs
Microbial Corrosion
Cardiovascular Drugs: Classification based on Therapeutic Indications
